SEMINAR: Intracellular vesicle trafficking of bone resorbing osteoclasts
|Intracellular vesicle trafficking of bone resorbing osteoclasts : School of Anatomy & Human Biology Seminar Series
Prof Ming-Hao Zheng is the Winthrop Professor and Director of Research at the Translational Orthopaedic Research Centre, Sir Charles Gairdner Hospital, Perth and the Associate Dean (International) of the Faculty of Medicine, Dentistry and Health Sciences, the University of Western Australia. He is also the Chung Kong Scholar Lecturing Professor and the Deputy Director of Australia-China Cooperative Research Centre for Biotherapeutics and Regenerative Medicine at the Zhejiang University, China, Director for UWA-Nanjing Bone and Joint Research Centre at Nanjing University. He has served on the editorial board for numbers of Orthopaedics and Pathology journals.
Prof Zheng completed his Bachelor of Medicine in 1983, Master of Medicine (Pathology) in 1987 in China, PhD in 1993 and Doctor of Medicine in 2000 at the University of Western Australia. Prof Zheng is a fellow of the Royal College of Pathologists and the Royal College of Pathologists of Australasia. He has focused on the development of an academic career in bone and joint research and regenerative medicine. His productivity is evidenced by the quality of publications and patents, and his ability to transform laboratory research into clinical practice. He has published over 120 peer-reviewed papers in journals including Nature Medicine, Annals of Internal Medicine, Journal of Clinical Investigation, Molecular Cellular Biology, Journal of Biological Chemistry, American Journal of Pathology and Journal of Bone and Mineral Research.
His major achievements include studies in the molecular and cellular biology of the osteoclast, clinical and laboratory evaluation of human bone allograft, development of cellscaffold technology for cartilage, tendon and bone regeneration and regulatory framework in human tissue and cellular products. His work on Giant Cell Tumour of bone (GCT) has been used by WHO for classification of bone tumours and has been recorded in the textbook “Ackermans Surgical Pathology”. He has 7 patents in the field of Orthopaedics and has introduced the concept and technology of autologous biotherapy in orthopaedics. His research results in the development of autologous stem cell and progenitor cell therapy in bone, cartilage and tendon. He has transformed the benchwork of Matrix-induced Autologous Chondrocyte Implantation (MACI) and Autologous Tencoyte Therapy (ATT) into clinical practices. In 2009, he was specially awarded by Genzyme in Boston for his leadership, commitment and dedication to the advancement of MACI. To date, more than 120 hospitals across Australia and over 8000 patients in the world have used MACI for the treatment of cartilage defects. Prof Zheng has actively supervised and nursed quality postgraduate students andpostdoctoral fellows with 21 PhD and 15 Master of Medical sciences students completing their degree in the last 15 years. Many of them have won awards at the national and international meetings for their research work and become high profile independent researchers. These include Prof Hiroshi Fujie, Prof Jiake Xu, and Asst/Prof Nathan Pavlos.
Prof Zheng is actively involved in the organisation of national and international societies in bone and cartilage research, and has held positions such as Councillor of the Australia & New Zealand Bone & Mineral Research Society (1999 - 2001), Treasurer/Secretary of the Australia & New Zealand Orthopaedic Research Society (2000 – 2003), member of the scientific committee of the International Bone and Mineral Society (2003), Chair of the Organising Committee of the Australian Biotherapeutics & Tissue Regeneration Forum (2003) and the International Cartilage Repair Society (2004), Session Chair of the 6th Combined Orthopaedic Meeting (2007) in Hawaii and The BIO 2008 in San Diego. Prof Zheng is also the Conveyor of the four Australian Biotherapeutic & Regenerative Medicine Forums. He is currently a member of the Therapeutics Goods Committee (Biologics) at the Therapeutics Goods Administration (TGA) appointed by the Minister of Health in Canberra.
Winthrop Professor Ming-Hao Zheng, Director of Research , Translational Orthopaedic Research Centre, SCGH & Associate Dean (International) Faculty of Medicine, Dentistry and Health Sciences, UWA
Anatomy & Human Biology building, 1st floor, seminar room (1.81)
: 6488 3290
Tue, 15 Nov 2011 13:00
Tue, 15 Nov 2011 14:00
Debbie Hull <[email protected]>
Mon, 14 Nov 2011 09:39
- Locations of venues on the Crawley and Nedlands campuses are
available via the Campus Maps website.
- Download this event as:
Mail this event: